Craneware plc Release and discharge of security in the Company

RNS Number : 5088D

Craneware plc

10 September 2024

 

 

Craneware plc

 

("Craneware", the "Craneware Group", the "Company" or the "Group")

 

Notice of release and discharge of security in the Company

 

10 September 2024 - Craneware (AIM: CRW.L), the market leader in Value Cycle solutions for the US healthcare market, is pleased to announce that following the satisfaction of certain performance conditions of the loan agreement entered into in connection with the acquisition of Sentry Data Systems Inc. ('Sentry'), the Security Trustee (acting on instructions of the Lenders) has released the securities granted at the time by the Company and the relevant subsidiaries which provided security over all of the assets of the Company and specified assets of the Group. As such the Company is now unencumbered by this security and is automatically, irrevocably, and unconditionally released, discharged and terminated of all the released assets from the fixed and floating charges, Liens and security interests constituted or intended to be constituted by the original security documents.

 

The loan agreement was originally entered into between Silicon Valley Bank, now known as HSBC Innovation Banking, and the Company's banking syndicate and their successors ('the Lenders'), to fund the acquisition of SDS Holdco, Inc., the ultimate holding company of Sentry on 12th July 2021. The debt facility comprised a term and revolving facilities agreement and was secured by a Scots law floating charge, an English law debenture and a New York law security agreement all of which were granted by the Company and certain of its subsidiaries as parties.

 

Keith Neilson, CEO of Craneware plc commented:

 

"We are pleased to have achieved this important milestone, demonstrating the considerable progress of the enlarged Group since the acquisition and integration of Sentry. Alongside meeting the conditions of the loan agreement, our strong performance and disciplined financial management allow us to invest in our solutions, pay down debt and accelerate the growth of The Craneware Group, for the benefit of all our stakeholders."

 

​

For further information, please contact:

 

Craneware plc	[phone]
Keith Neilson, CEO
Craig Preston, CFO
Alma Strategic Communications (Financial PR)	[phone]
Caroline Forde, Kinvara Verdon	[e-mail]
Peel Hunt (NOMAD and Joint Broker)	[phone]
Neil Patel, Benjamin Cryer, Kate Bannatyne
Investec Bank PLC (Joint Broker)	[phone]
Patrick Robb, Henry Reast, Shalin Bhamra
Berenberg (Joint Broker)	[phone]
Mark Whitmore, Richard Andrews, Dan Gee-Summons

 

 

About Craneware

 

The Craneware Group (AIM:CRW.L), is the market leader in value cycle solutions. For 25 years, we have collaborated with U.S. healthcare providers to optimize revenue integrity, pricing intelligence, decision support, labor productivity, business of pharmacy, and 340B program management.  

 

Customers choose Trisus®, a HITRUST- and SOC2 Type II-certified, SaaS-platform, to achieve operational and financial excellence in pursuit of their healthcare mission - delivering quality care to their communities. The Craneware Group - Transforming the Business of Healthcare.

 

Learn more at www.craneware.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

MSCQKCBNBBKBBCK